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Abstract - Two mediastinal masses were 
incidentally detected at high resolution computed 
tomography (HRCT) of a 72 year-old male patient, 
former smoker, affected by chronic obstructive 
pulmonary disease with worsening dyspnea and 2-year 
medical history of polycythemia secondary to hypoxia. 
Integration with a multidetector computed tomography 
(MDCT) scan after administration of intravenous 
injection contrast medium showed slightly 
inhomogeneous increase of enhancement of masses, 
suggesting in the first case potential malignancy. 
Diagnosis of extramedullary hematopoiesis was 
achieved by fine needle aspiration citology (FNAC). 
Extramedullary hematopoiesis  must be considered in 
differential diagnosis in patients with medical history of 
polycythemia and severe hypoxia. 
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A 72 year-old male patient was admitted to the 
department of Respiratory Medicine Division with a 10-
day history of worsening dyspnea also with minimal 
exertion and muco-purulent sputum to chronic 
obstructive pulmonary disease (COPD).  He presented a 
2-years medical history of polycythemia secondary to 
hypoxia, and for these reasons underwent periodic 
phlebotomies. He was smoker (30 cigarettes / day for 
45 years) with a history of  pulmonary heart disease 
with moderate  pulmonary hypertension, diabetes 
mellitus, hypertension and respiratory failure, treated  
with oral hypoglycemic agents, diuretics, acetylsalicylic 
acid, and O2 therapy for 24h/die.  
Body temperature was normal. Physical examination  
showed dyspnea at rest, acral cyanosis and peripheral 
edema and splenomegaly. Physical examination of the 
chest revealed bronchostenosis and rales on both lower 
field of lungs. 
Laboratory analysis showed the following: red blood 
cell (RBC) 6.41x1012/l; hemoglobin (Hb) 15 g/dl; mean 
corpuscular volume (MCV) 86.3 fl; hematocrit ( HCT ) 
55.3 %; mean corpuscular hemoglobin (MCH) 23.4 pg; 
mean corpuscular hemoglobin concentration (MCHC) 
27.1 g/dl; red blood cell distribution width - coefficient 
variation (RDW-CV), 19.1%; red blood cell distribution 
width - standard deviation (RDW-SD) 56.1 fl; WBC 
8.18x109/l; PLT 127x109/l.  
Arterial blood gas analysis showed an hypoxaemic 
hypercapnic  respiratory failure, with respiratory 
acidosis : pH 7.329; pCO2 69.7 mmHg; pO2 42.0 
mmHg; cHCO-3 29.8 mmol/L; cBase: 9.6 mmol/L;   
flow-volume spirometry  test showed a restrictive 
pattern with obstructive component : forced vital 
capacity (FVC) 35% (teor. 3.12 lt, meas. 1.08 lt); forced 
expiratory volume 1 second (FEV1) 31% (teor. 2.39 lt, 
meas. 0.75 lt) ; Tiffeneau Index FEV1/FVC 74.3%; 
peak expiratory flow (PEF) 32% (teor. 7 lt/sec, meas 
2.21 lt/sec) ; forced expiratory flows FEF25% 19% (teor. 
6.29lt/sec, meas. 1.21 lt/sec); FEF50% 15% (teor. 3.56, 
meas. 0,52 lt/sec); FEF75% 27% (teor. 1.01 lt/sec, meas. 
0.27 lt/sec). Coagulation profile, amylase and lipase 
levels were normal. Hepatitis screen was negative. 
Chest X-Ray during his workup in the hospital showed 
diffuse thickening of peribronchial interstitium; spine 
did not show any X-Ray abnormality (Fig. 1a -b).   
Chest high resolution computed tomography (HRCT) 
showed the peribronchial thickening, typical of COPD 
and peripheral areas of parenchymal consolidation in 
the medial segment of the middle lobe and lingula; 
interstitium was not tickened. (Fig. 2a-b). 
HRCT scan of the chest showed two masses occupying 
left and right paravertebral mediastinal regions, that 
required a volumetric multidetector computed 
tomography (MDCT)  scan before and after intravenous  
administration of contrast medium (Fig. 3). 
MDCT scan confirmed the presence of two lobulated 
masses with dense soft parts; borders were smooth and 
there was not calcification inside. Masses were located 
into the posterior mediastinum showing a paravertebral 
distribution at the level of the tenth thoracic vertebra 
(Fig. 4A). After intravenous administration of contrast 
medium, masses showed slightly inhomogeneous 
density enhancement (Fig. 4B). 
Multiplanar reconstructions (MPR) at the anatomic 
levels of symmetric lesions were performed. Maximum 
extension was 33 mm on coronal view. Tenth thoracic 
vertebra, showed demineralization signs compatible 
with angiomatous lesion without bone erosion. Other 
finding was splenomegaly (bipolar diameter 140 mm; 
normal value 90-120 mm) (Fig. 5a-b-c). 
Lymphadenopathy and hepatomegaly were not detected  
Considering the haematological exams, history and risk 
factors (the patient was a former heavy smoker) with  
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Fig. 1. A 72 years-old male affected by polycythemia and COPD. 
(1A) Postero-anterior and (1B) lateral chest X-Ray show diffuse 






Fig. 2.  Axial view of  HRCT shows the peribronchial thickening 
(white arrows)  and peripheral areas of parenchymal consolidation 
(black arrows) into the middle lobe and lingula. 
 
 
radiological findings and absence of specific signs and 
symptoms other than a COPD reactivation we 
considered the differential diagnosis with neurogenic 
tumors. 
CT guided percutaneous fine needle aspiration cytology 
(FNAC) was performed on left paravertebral mass and 
confirmed the diagnosis of extramedullary 
hematopoiesis (EMH) (Fig. 6). 
The patient started a closer follow up for respiratory 
failure and hematological changes; with a more 
adequate therapy with maximum dose of bronchodilator 
drugs (beta2 agonists with corticosteroids 50/500 mcg 
twice a day and anticholinergic  drugs once a day) and 
an increase of O2 to 2 lit. per minute at rest and during 
night, and 2.5 lit. per minute under exercise during 24 
hours , with bi-level  positive airway pressure (BPAP) ,  
the last  hematocrit (HTC)  was 50.6 %, the red blood 
cells count (RBC) was  5.85x1012/lit , hemoglobin (Hb) 
was 13.7 g/lit, while the CT scan confirmed the 
approximately same dimensions of masses. The patient 
underwent to a single phlebotomy during follow up. 
 
 
IV.  DISCUSSION 
 
EMH is considered a physiological compensatory 
mechanism, characterized by proliferation of 
hematopoietic cells outside the bone marrow, occurring 




Fig. 3.  Axial view of  HRCT shows two masses (white arrows) 





Fig. 4. Axial view of  MDCT shows: (4A) two lobulated masses 
(white arrows) with dense soft parts and smooth borders, Masses were 
located into the posterior mediastinum showing a paravertebral 
distribution at the level of the tenth thoracic vertebra (4B) After 
intravenous administration of contrast medium, the masses showed 
slightly inhomogeneous density enhancement (white arrowhead). 
 
 
EMH is often associated with congenital 
hemoglobinopathies (thalassemia, sickle cell anemia, 
and spherocytosis) or with acquired bone marrow  
replacement disorders (leukemia, lymphoma, 
myelodysplasia, and myelofibrosis) [2-5]. 
Extramedullary hematopoiesis tissue usually develops 
in sites related to hematopoiesis during fetal 
development [6-8]; experimental studies suggest that 
muscular and neural tissues can produce hematopoietic 
cells when stimulated by certain conditions; this effect 
is given by subpopulations of cells that possess  
pluripotent potential as reminiscence of embryonic stem  
cells, and remained unrestricted in specific tissues [9]; 
the most common sites include liver, spleen and lymph 
nodes. It may occurs also in kidneys, pleura, skin, 
ovaries, intestine, sclera, central nervous system, 
epidural space, and adrenal glands, less common is 
intra-thoracic EMH [10-11]. EMH causes usually no 
symptoms and develops slowly over time, but spinal 
cord compression [6] and spontaneous rupture [12] have 
been described. The most common presenting symptom 
into malignant neoplasms is local vertebral pain that 
may be accompanied by radicular pain and paresthesia. 
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Fig. 5. Coronal view of MDCT after intravenous  administration of 
contrast  medium: (5A) demineralization of the 10th thoracic vertebra 
(white arrowhead) without bone erosion; (5B) masses’ craniocaudal 





Fig. 6. Fine-needle aspiration cytology of right paravertebral 
mediastinal mass at the level of the 10th thoracic vertebra shows 
trilineage hematopoiesis with complete cellular maturation 
characteristic of active hematopoietic tissue. Megakaryocyte in the 
middle (white arrow) of the field and small clusters of erythroblasts 
(black arrowhead) without evidence of adipocytes are typical findings 
for active hematopoietic tissue. 
 
EMH causes usually no symptoms and findings are 
incidental. Diagnosis of intra-thoracic EMH can be 
suspected on a chest X-Ray, CT or magnetic resonance  
imaging (MRI) [13].  
Chest X-Ray is often normal, but if intra-thoracic EMH 
is large, it may show paravertebral lobulated masses 
with well-defined borders, usually bilateral, without 
calcifications or bone erosion. Bone lesions, if present, 
are related to underlying disease [14-16].  
On CT scan, intra-thoracic EMH is characterized by 
presence of lobulated masses with dense soft parts, 
usually homogeneous with smooth borders, without 
calcification inside and may be present adipose tissue 
within the mass. Usually those masses are bilateral and 
located below the level of the sixth thoracic vertebra 
[17-18]. After intravenous administration of contrast 
medium, the masses show homogeneous density 
enhancement because of their high vascularity [19], but 
CT scan may reveal an inhomogeneous density 
enhancement if occurs fat infiltration.   
MRI may be useful to identify adipose tissue within the 
mass and demonstrate thoracic rib expansion without 
evidence of cortical bone erosion. EMH masses usually 
present low signal on both T1w and T2w images; after 
intravenous administration of contrast medium, is 
evidence of low enhancement, although EMH tissue is 
highly vascular [19]. 
Radionuclide bone scintigraphy using 99mTc sulfur 
colloid or 111In   has a role not yet been clarified, but it 
can be used to demonstrate areas of focal uptake of the 
tracer localizing to paravertebral masses (hematopoietic 
activity) [20].  
The diagnosis can be obtained with FNAC, open 
biopsy, or thoracoscopic biopsy in uncertain cases [21].  
Other causes of posterior mediastinal masses include 
neurogenic tumors (such as schwannoma, neurofibroma 
and ganglioneuroma), benign bone tumors of the spine 
(such as aneurysmal bone cyst and fibrous dysplasia), 
mesenchymal tumor, hemangioma, lymphangioma, 
malignant neoplasms (metastases, lymphoma, multiple 
myeloma, and Ewing sarcoma), infective etiologies 
(tuberculosis, nocardia and actinomyces) [19]. 
Calcifications in patients with EMH is demonstrated 
extremely rarely [22]. In tuberculosis, lymph nodes 
show commonly peripherally enhancement [23]; in 
lymphomas, enhancement is usually slight and 
homogeneous. Neurogenic tumors of the posterior 
mediastinum commonly have erosions or defects of the 
vertebrae or ribs and may show moderate homogeneous 
contrast enhancement. EMH is exclusively extradural, a 
feature that cannot always be distinguished with 
imaging, while schwannomas occur most commonly in 
the context of meningeal dural layer, but they can occur 
outside of meningeal dural layer [24]. EMH treatment 
includes corticosteroids, blood transfusion, 
hydroxyurea, splenectomy in cases of spherocytosis, 




[1] Marchiori E, Escuissato DL, Irion KL, Zanetti 
G, Rodrigues RS, Meirelles GS, Hochhegger B. 
Extramedullary hematopoiesis: findings on computed 
tomography scans of the chest in 6 patients. J Bras 
Pneumol 2008;34:812-816. 
[2] Wyatt SH, Fishman EK. Diffuse pulmonary 
extramedullary hematopoiesis in a patient with 
myelofibrosis: CT findings. J Comput Assist Tomogr 
1994;18:815-817.  
[3] Ejindu VC, Hine AL, Mashayekhi M, Shorvon 
PJ, Misra RR. Musculoskeletal manifestations of sickle 
cell disease. Radiographics 2007;27(4):1005-1021. Lall 
C, Payne DK.  
[4] Lall C, Payne DK. A patient with anemia and a 
paraspinal chest mass. Chest 2003;124:732-734.  
[5] Kwak HS, Lee JM. CT findings of 
extramedullary hematopoiesis in the thorax, liver and 
Translational Medicine @ UniSa - ISSN 2239-9747 2016, 14(1): 1-4
 
4 
Università degli Studi di Salerno 
kidneys, in a patient with idiopathic myelofibrosis. J 
Korean Med Sci 2000;15:460-462.  
[6] Ohta Y, Shichinohe H, Nagashima K. Spinal 
cord compression due to extramedullary hematopoiesis 
associated with polycythemia vera - case report. Neurol 
Med Chir 2002;42:40-43.  
[7] Amirjamshidi A, Abbassioun K, Ketabchi SE. 
Spinal extradural hematopoiesis in adolescents with 
thalassemia. Report of two cases and a review of the 
literature. Childs Nerv Syst 1991;7:223-225.  
[8] King BF, Kopecky KK, Baker MK, Clark SA. 
Extramedullary hematopoiesis in the adrenal  glands: 
CT characteristics. J Comput Assist Tomogr 
1987;11:342-343.  
[9] Jay KE, Gallacher L, Bhatia M. Emergence of 
muscle and neural hematopoiesis in humans. Blood 
2002;100:3193-202. 
[10] Kwak HS, Lee JM. CT findings of 
extramedullary hematopoiesis in the thorax, liver and 
kidneys, in apatient with idiopathic myelofibrosis. J 
Korean Med Sci 2002;15:460-462.  
[11] Wyatt SH, Fishman EK. Diffuse pulmonary 
extramedullary hematopoiesis in a patient with 
myelofibrosis: CT findings. J Comput Assist Tomogr 
1994;18:815-817.  
[12] Pornsuriyasak P, Suwatanapongched T, 
Wangsuppasawad N, Ngodngamthaweesuk M, 
Angchaisuksiri P. Massive hemothorax in a beta-
thalassemic patient due to spontaneous rupture of 
extramedullary hematopoietic masses: diagnosis and 
successful treatment. Respir Care 2006;51:272-276.  
[13] Tsitouridis J, Stamos S, Hassapopoulou E, 
Tsitouridis K, Nikolopoulos P. Extramedullary 
paraspinal hematopoiesis in thalassemia: CT and MRI 
evaluation. Eur J Radiol 1999;30:33-38.  
[14] Ejindu VC, Hine AL, Mashayekhi M, Shorvon 
PJ, Misra RR. Musculoskeletal  manifestations of sickle 
cell disease. Radiographics 2007;27:1005-1021.  
[15] Ganguly A, Boswell W, Aniq H.  
Musculoskeletal manifestations of sickle cell anaemia: a 
pictorial review. Anemia. 2011:794283. doi: 
10.1155/2011/794283 
[16] Martinoli C, Bacigalupo L, Forni GL, Balocco 
M, Garlaschi G, Tagliafico A. Musculoskeletal 
manifestations of chronic anemias. Semin 
Musculoskelet Radiol 2001;15(3):269-280  
[17] Ng CS, Wan S, Underwood MJ, Yim AP. 
Video-assisted thoracic surgery and extramedullary 
haematopoiesis. Eur Respir J 2006;28:255-256  
[18] Hedlund J, Strålin K, Ortqvist A, Holmberg H. 
Community-Acquired Pneumonia Working Group of 
the Swedish Society of Infectious Diseases. Swedish 
guidelines for the management of community-acquired 
pneumonia in immunocompetent adults. Scand J Infect 
Dis. 2005;37:791-805.  
[19] Cherian V, Machnicki S. Posterior mediastinal 
masses in a patient with exacerbation of Crohn disease. 
Chest 2007;131:1963-1966.  
[20] Choi H, David CL, Katz RL, Podoloff DA. 
Case 69: extramedullary hematopoiesis. Radiology 
2004;231:52-56.  
[21] Berkmen YM, Zalta BA. Case 126: 
extramedullary hematopoiesis. Radiology. 
2007;245:905-908.  
[22] Xiros N, Economopoulos T, Papageorgiou E, 
Mantzios G, Raptis S. Massive hemothorax due to 
intrathoracic extramedullary hematopoiesis in a patient 
with hereditary spherocytosis.Ann Hematol. 
2001;80:38-40. 
[23] Im JG, Song KS, Kang HS, Park JH, Yeon 
KM, Han MC, Kim CW. Mediastinal tuberculous 
lymphadenitis: CT manifestations.Radiology. 
1987;164:115-9. 
[24] Kurtman C, Ozbilgin MK, Andrieu MN, 
Celebioglu B. Paratracheal extramedullary 
hematopoiesis.Paratracheal extramedullary 
hematopoiesis.Int J Hematol. 2001;73:492-5. 
 
 
